134 related articles for article (PubMed ID: 23996518)
1. Olive oil attenuates the cholesterol-induced development of nonalcoholic steatohepatitis despite increased insulin resistance in a rodent model.
Buettner R; Ascher M; Gäbele E; Hellerbrand C; Kob R; Bertsch T; Bollheimer LC
Horm Metab Res; 2013 Oct; 45(11):795-801. PubMed ID: 23996518
[TBL] [Abstract][Full Text] [Related]
2. Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome.
Buettner R; Bettermann I; Hechtl C; Gäbele E; Hellerbrand C; Schölmerich J; Bollheimer LC
Horm Metab Res; 2010 Oct; 42(11):769-74. PubMed ID: 20803414
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
[TBL] [Abstract][Full Text] [Related]
4. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.
Buettner R; Parhofer KG; Woenckhaus M; Wrede CE; Kunz-Schughart LA; Schölmerich J; Bollheimer LC
J Mol Endocrinol; 2006 Jun; 36(3):485-501. PubMed ID: 16720718
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
6. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
Matsuzawa N; Takamura T; Kurita S; Misu H; Ota T; Ando H; Yokoyama M; Honda M; Zen Y; Nakanuma Y; Miyamoto K; Kaneko S
Hepatology; 2007 Nov; 46(5):1392-403. PubMed ID: 17929294
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats.
Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y
Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627
[TBL] [Abstract][Full Text] [Related]
10. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
[TBL] [Abstract][Full Text] [Related]
11. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.
Mells JE; Fu PP; Kumar P; Smith T; Karpen SJ; Anania FA
J Nutr Biochem; 2015 Mar; 26(3):285-92. PubMed ID: 25577467
[TBL] [Abstract][Full Text] [Related]
12. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
Safwat GM; Pisanò S; D'Amore E; Borioni G; Napolitano M; Kamal AA; Ballanti P; Botham KM; Bravo E
Nutrition; 2009; 25(11-12):1157-68. PubMed ID: 19592219
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.
Basciano H; Miller AE; Naples M; Baker C; Kohen R; Xu E; Su Q; Allister EM; Wheeler MB; Adeli K
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E462-73. PubMed ID: 19509184
[TBL] [Abstract][Full Text] [Related]
14. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
[TBL] [Abstract][Full Text] [Related]
16. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
Matsunami T; Sato Y; Ariga S; Sato T; Shimomura T; Kashimura H; Hasegawa Y; Yukawa M
Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698
[TBL] [Abstract][Full Text] [Related]
17. Oat β-glucan inhibits lipopolysaccharide-induced nonalcoholic steatohepatitis in mice.
You S; Hu X; Zhao Q; Chen X; Xu C
Food Funct; 2013 Sep; 4(9):1360-8. PubMed ID: 23851679
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
20. Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic function.
Thomsen KL; Grønbæk H; Glavind E; Hebbard L; Jessen N; Clouston A; George J; Vilstrup H
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G295-301. PubMed ID: 24924745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
